SU1424722A3 - Способ получени цисплатины - Google Patents
Способ получени цисплатины Download PDFInfo
- Publication number
- SU1424722A3 SU1424722A3 SU833643499A SU3643499A SU1424722A3 SU 1424722 A3 SU1424722 A3 SU 1424722A3 SU 833643499 A SU833643499 A SU 833643499A SU 3643499 A SU3643499 A SU 3643499A SU 1424722 A3 SU1424722 A3 SU 1424722A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- freeze
- solution
- cisplatinum
- dried
- drying
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 8
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Substances [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 title claims description 20
- 229910052697 platinum Inorganic materials 0.000 title claims description 11
- 238000004090 dissolution Methods 0.000 claims abstract description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 11
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 6
- 229930195725 Mannitol Natural products 0.000 claims description 5
- 235000010355 mannitol Nutrition 0.000 claims description 5
- 239000000594 mannitol Substances 0.000 claims description 5
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims 2
- 229960004316 cisplatin Drugs 0.000 claims 2
- 238000002360 preparation method Methods 0.000 abstract description 10
- 239000000203 mixture Substances 0.000 abstract description 7
- 238000004108 freeze drying Methods 0.000 abstract 3
- 238000004519 manufacturing process Methods 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001298 alcohols Chemical class 0.000 abstract 1
- 230000000259 anti-tumor effect Effects 0.000 abstract 1
- 239000012736 aqueous medium Substances 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 239000002609 medium Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 16
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 12
- 238000001035 drying Methods 0.000 description 10
- 239000003708 ampul Substances 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 239000008215 water for injection Substances 0.000 description 7
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 6
- 235000019441 ethanol Nutrition 0.000 description 6
- 230000008014 freezing Effects 0.000 description 6
- 238000007710 freezing Methods 0.000 description 6
- 239000011521 glass Substances 0.000 description 6
- 239000011780 sodium chloride Substances 0.000 description 6
- 150000004985 diamines Chemical class 0.000 description 5
- 239000008227 sterile water for injection Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000003814 drug Substances 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- -1 Platinum (II) diamine Chemical class 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 229920005549 butyl rubber Polymers 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/243—Platinum; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT23396/82A IT1153974B (it) | 1982-09-23 | 1982-09-23 | Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU1424722A3 true SU1424722A3 (ru) | 1988-09-15 |
Family
ID=11206716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU833643499A SU1424722A3 (ru) | 1982-09-23 | 1983-09-15 | Способ получени цисплатины |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4670262A (enExample) |
| JP (1) | JPS5978117A (enExample) |
| AT (1) | AT382077B (enExample) |
| AU (1) | AU559499B2 (enExample) |
| BE (1) | BE897761A (enExample) |
| CA (1) | CA1211372A (enExample) |
| CH (1) | CH655852A5 (enExample) |
| DE (1) | DE3333024A1 (enExample) |
| DK (1) | DK157168C (enExample) |
| FI (1) | FI78236C (enExample) |
| FR (1) | FR2533439B1 (enExample) |
| GB (1) | GB2127291B (enExample) |
| GR (1) | GR79055B (enExample) |
| IE (1) | IE56173B1 (enExample) |
| IL (1) | IL69752A (enExample) |
| IT (1) | IT1153974B (enExample) |
| NL (1) | NL8303211A (enExample) |
| SE (1) | SE464061B (enExample) |
| SU (1) | SU1424722A3 (enExample) |
| ZA (1) | ZA836904B (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2178702C1 (ru) * | 2001-02-21 | 2002-01-27 | Общество с ограниченной ответственностью "Нобель" | Антираковое средство |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8303657A (nl) * | 1983-10-24 | 1985-05-17 | Pharmachemie Bv | Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan. |
| ES8801168A1 (es) * | 1984-11-02 | 1987-02-16 | Johnson Matthey Plc | Procedimiento para la obtencion de un compuesto de platino para utilizar en quimioterapia del cancer. |
| JPH0665648B2 (ja) * | 1985-09-25 | 1994-08-24 | 塩野義製薬株式会社 | 白金系抗癌物質の安定な凍結真空乾燥製剤 |
| JP2524217B2 (ja) * | 1988-04-18 | 1996-08-14 | マルハ株式会社 | 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤または痴呆治療剤 |
| FI895340A7 (fi) * | 1988-11-14 | 1990-05-15 | Bristol Myers Squibb Co | Hypertoninen cisplatin-liuos |
| US20030148933A1 (en) * | 1990-10-01 | 2003-08-07 | Pharma Mar S.A. | Derivatives of dehydrodidemnin B |
| DE69322251T2 (de) * | 1992-09-04 | 1999-07-29 | Fuji Kagaku Kogyo K.K., Toyama | Medizinische zusammensetzung |
| FR2759293B1 (fr) * | 1997-02-11 | 1999-04-30 | Ethypharm Lab Prod Ethiques | Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie |
| GB9803448D0 (en) | 1998-02-18 | 1998-04-15 | Pharma Mar Sa | Pharmaceutical formulation |
| SK287762B6 (sk) * | 1999-11-15 | 2011-09-05 | Pharma Mar, S. A. | Použitie aplidínu na prípravu farmaceutického prostriedku na liečenie rakoviny |
| UA76718C2 (uk) * | 2000-06-30 | 2006-09-15 | Фарма Мар, С.А. | Протипухлинні похідні аплідину |
| HK1054191A1 (zh) * | 2000-10-12 | 2003-11-21 | Pharma Mar, S.A. | 施用aplidine時同時使用myoprotector的癌症治療 |
| EP2251344B2 (en) | 2001-01-25 | 2024-04-24 | THE UNITED STATES OF AMERICA, represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES | Formulation of boronic acid compounds |
| US7351431B2 (en) * | 2001-09-21 | 2008-04-01 | Dainippon Sumitomo Pharma Co., Ltd. | Freeze-dried pharmaceutical preparation |
| AU2002336206B2 (en) * | 2001-10-19 | 2007-11-29 | Pharma Mar, S.A. | Use of aplidine for the treatment of pancreatic cancer |
| WO2004080477A1 (en) * | 2003-03-12 | 2004-09-23 | Dana-Farber Cancer Institute, Inc. | Aplidine for multiple myeloma treatment |
| JP2006519848A (ja) * | 2003-03-12 | 2006-08-31 | ファルマ・マール・ソシエダード・アノニマ | 改良された抗腫瘍治療 |
| DE50305909D1 (de) * | 2003-10-13 | 2007-01-18 | Salama Zoser B | Pharmazeutische Zusammensetzung umfassend Oxoplatin und dessen Salze |
| US8436190B2 (en) * | 2005-01-14 | 2013-05-07 | Cephalon, Inc. | Bendamustine pharmaceutical compositions |
| KR20140101014A (ko) * | 2006-02-28 | 2014-08-18 | 파르마 마르 에스.에이. | 개선된 항종양 치료 |
| JP2011500650A (ja) * | 2007-10-19 | 2011-01-06 | ファルマ・マール・ソシエダード・アノニマ | 改良された抗腫瘍治療 |
| EP2262523A1 (en) * | 2008-03-07 | 2010-12-22 | Pharma Mar S.A. | Improved anticancer treatments |
| AR072777A1 (es) | 2008-03-26 | 2010-09-22 | Cephalon Inc | Formas solidas de clorhidrato de bendamustina |
| WO2010036702A1 (en) | 2008-09-25 | 2010-04-01 | Cephalon, Inc. | Liquid formulations of bendamustine |
| CN107773538B (zh) * | 2016-08-27 | 2022-09-13 | 鲁南制药集团股份有限公司 | 稳定的甲啶铂无菌冻干粉末及其制备工艺 |
| JOP20190254A1 (ar) | 2017-04-27 | 2019-10-27 | Pharma Mar Sa | مركبات مضادة للأورام |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1432563A (en) * | 1972-04-10 | 1976-04-22 | Rustenburg Platinum Mines Ltd | Platinum- co-ordination compounds |
| GB1432562A (en) * | 1972-04-10 | 1976-04-22 | Rustenburg Platinum Mines Ltd | Platinum co-ordination compounds |
| US4053587A (en) * | 1973-04-13 | 1977-10-11 | Research Corporation | Method of treating viral infections |
| US4255417A (en) * | 1976-08-04 | 1981-03-10 | Johnson Matthey, Inc. | Platinum compounds for the irradication of skin blemishes |
| SE445172B (sv) * | 1978-05-30 | 1986-06-09 | Bristol Myers Co | Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform |
| US4273755A (en) * | 1979-08-16 | 1981-06-16 | Mpd Technology Corporation | Preparation of platinum complexes |
| US4302446A (en) * | 1979-10-02 | 1981-11-24 | Bristol-Myers Company | Pharmaceutical compositions |
| US4451447A (en) * | 1980-03-31 | 1984-05-29 | Bristol-Myers Company | Pharmaceutical formulations |
| AU541056B2 (en) * | 1980-03-31 | 1984-12-13 | Bristol-Myers Company | Pharmaceuticals formulations |
-
1982
- 1982-09-23 IT IT23396/82A patent/IT1153974B/it active
-
1983
- 1983-09-12 GB GB08324380A patent/GB2127291B/en not_active Expired
- 1983-09-13 AT AT0326283A patent/AT382077B/de active
- 1983-09-13 DE DE3333024A patent/DE3333024A1/de not_active Withdrawn
- 1983-09-13 AU AU19089/83A patent/AU559499B2/en not_active Ceased
- 1983-09-13 SE SE8304920A patent/SE464061B/sv not_active IP Right Cessation
- 1983-09-14 JP JP58168513A patent/JPS5978117A/ja active Pending
- 1983-09-15 GR GR72452A patent/GR79055B/el unknown
- 1983-09-15 SU SU833643499A patent/SU1424722A3/ru active
- 1983-09-15 BE BE0/211538A patent/BE897761A/fr not_active IP Right Cessation
- 1983-09-15 CH CH5037/83A patent/CH655852A5/de not_active IP Right Cessation
- 1983-09-15 FI FI833300A patent/FI78236C/fi not_active IP Right Cessation
- 1983-09-16 IL IL69752A patent/IL69752A/xx unknown
- 1983-09-16 IE IE2172/83A patent/IE56173B1/en unknown
- 1983-09-16 FR FR8314772A patent/FR2533439B1/fr not_active Expired
- 1983-09-16 NL NL8303211A patent/NL8303211A/nl not_active Application Discontinuation
- 1983-09-16 ZA ZA836904A patent/ZA836904B/xx unknown
- 1983-09-16 DK DK424383A patent/DK157168C/da not_active IP Right Cessation
- 1983-09-20 CA CA000437117A patent/CA1211372A/en not_active Expired
-
1985
- 1985-05-28 US US06/738,436 patent/US4670262A/en not_active Expired - Fee Related
Non-Patent Citations (1)
| Title |
|---|
| Amulla Hincal Parenterd Diug Assoe. 33, 1979, 3, с. 107-116. * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2178702C1 (ru) * | 2001-02-21 | 2002-01-27 | Общество с ограниченной ответственностью "Нобель" | Антираковое средство |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2533439A1 (fr) | 1984-03-30 |
| DE3333024A1 (de) | 1984-03-29 |
| FI78236B (fi) | 1989-03-31 |
| AU1908983A (en) | 1984-03-29 |
| IE832172L (en) | 1984-03-23 |
| SE8304920L (sv) | 1984-03-24 |
| AT382077B (de) | 1987-01-12 |
| FI833300A7 (fi) | 1984-03-24 |
| IL69752A0 (en) | 1983-12-30 |
| NL8303211A (nl) | 1984-04-16 |
| ZA836904B (en) | 1984-10-31 |
| ATA326283A (de) | 1986-06-15 |
| GB8324380D0 (en) | 1983-10-12 |
| IE56173B1 (en) | 1991-05-08 |
| GB2127291A (en) | 1984-04-11 |
| JPS5978117A (ja) | 1984-05-04 |
| FR2533439B1 (fr) | 1986-08-14 |
| GB2127291B (en) | 1986-01-15 |
| GR79055B (enExample) | 1984-10-02 |
| AU559499B2 (en) | 1987-03-12 |
| FI833300A0 (fi) | 1983-09-15 |
| DK424383D0 (da) | 1983-09-16 |
| IT1153974B (it) | 1987-01-21 |
| IL69752A (en) | 1986-07-31 |
| DK157168B (da) | 1989-11-20 |
| FI78236C (fi) | 1989-07-10 |
| SE8304920D0 (sv) | 1983-09-13 |
| SE464061B (sv) | 1991-03-04 |
| US4670262A (en) | 1987-06-02 |
| DK424383A (da) | 1984-03-24 |
| BE897761A (fr) | 1984-01-02 |
| CH655852A5 (de) | 1986-05-30 |
| CA1211372A (en) | 1986-09-16 |
| IT8223396A0 (it) | 1982-09-23 |
| DK157168C (da) | 1990-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU1424722A3 (ru) | Способ получени цисплатины | |
| FI116270B (fi) | Menetelmä stabiloidun prostaglandiini E1:n formulaation valmistamiseksi | |
| US10869848B2 (en) | Carmustine pharmaceutical composition | |
| US10617649B2 (en) | Preparation method of azacitidine for injection | |
| CA1056729A (en) | Injectable amoxycillin composition | |
| US6342530B1 (en) | Composition and method for parenteral administration of ibuprofen d,l- or l-lysine salt | |
| KR20250010131A (ko) | 보르테조밉 에스테르 용액의 제조 방법 | |
| CN114767829A (zh) | 一种不含防腐剂的缩宫素组合物及其制备方法和应用 | |
| KR20250010130A (ko) | 즉시 사용 가능한 보르테조밉 용액 | |
| AU598602B2 (en) | Ifosphamide lyophilisate and process for its preparation | |
| JPH07196517A (ja) | 安定な凍結乾燥済みチオテパ組成物 | |
| US5972912A (en) | Method for lyophilizing ifosfamide | |
| RU2096043C1 (ru) | Антигипоксическое средство и способ его получения | |
| JP2021138649A (ja) | スガマデクス含有の液体製剤及びその製造方法 | |
| CN113197848A (zh) | 一种重酒石酸间羟胺药物组合物及其制备方法 | |
| JP7423028B2 (ja) | ボルテゾミブを含有する凍結乾燥医薬組成物 | |
| RU2404797C1 (ru) | КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ЧЕЛОВЕЧЕСКИЙ РЕКОМБИНАНТНЫЙ ИНТЕРФЕРОН АЛЬФА-2b, И ЛЕКАРСТВЕННОЕ СРЕДСТВО ПРОЛОНГИРОВАННОГО ДЕЙСТВИЯ ДЛЯ ВЕТЕРИНАРИИ НА ЕЕ ОСНОВЕ, ОБЛАДАЮЩЕЕ ПРОТИВОВИРУСНЫМ И ИММУНОМОДУЛИРУЮЩИМ ДЕЙСТВИЕМ | |
| EP0619735A1 (en) | Lyophilized composition containing s(+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione) | |
| RU93028319A (ru) | Способ получения сарколизина для внутренних инъекций | |
| RU2504376C1 (ru) | Высокостабильный фармацевтический состав на основе лиофилизата производных 3-оксипиридинов, или метилпиридинов, или их фармацевтически приемлемых солей | |
| RU2329052C2 (ru) | Фармацевтическая композиция, способ ее получения и терапевтическое применение | |
| EP0369714A1 (en) | Cisplatin hypertonic solution | |
| JP2018123114A (ja) | ダルベポエチンを含む液体医薬組成物 | |
| CN110314132B (zh) | 一种门冬氨酸鸟氨酸注射液及其制备方法 | |
| JP6172880B1 (ja) | ダルベポエチンを含む液体医薬組成物 |